Skip to main content
Premium Trial:

Request an Annual Quote

Gene Security Network Raises $6M

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Gene Security Network has closed a $6 million Series B round of financing, the Redwood City, Calif.-based firm said today.
 
The company is developing its Parental Support technology, which uses data informatics to deliver single-cell testing for chromosome abnormalities and genetic diseases. GSN also operates a CLIA-certified lab in California, providing testing services to help guide physicians in selecting embryos during in vitro fertilization.
 
“Our technology will enable a host of services that make genetic information actionable, so that doctors worldwide can order tests to improve the quality of life for their patients,” GSN President and CEO Matthew Rabinowitz said in a statement.
 
The firm’s existing investors, Claremont Creek Ventures and Sequoia Capital, participated in the round of financing along with new investor Alafi Capital.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.